U.S. Markets closed
  • S&P 500

    3,577.59
    +20.05 (+0.56%)
     
  • Dow 30

    29,591.27
    +327.79 (+1.12%)
     
  • Nasdaq

    11,880.63
    +25.66 (+0.22%)
     
  • Russell 2000

    1,818.30
    +32.96 (+1.85%)
     
  • Crude Oil

    42.84
    -0.22 (-0.51%)
     
  • Gold

    1,835.20
    -2.60 (-0.14%)
     
  • Silver

    23.61
    -0.02 (-0.10%)
     
  • EUR/USD

    1.1846
    -0.0017 (-0.1421%)
     
  • 10-Yr Bond

    0.8570
    +0.0280 (+3.38%)
     
  • Vix

    22.66
    -1.04 (-4.39%)
     
  • GBP/USD

    1.3326
    +0.0034 (+0.2585%)
     
  • USD/JPY

    104.5040
    +0.6760 (+0.6511%)
     
  • BTC-USD

    18,354.06
    -100.69 (-0.55%)
     
  • CMC Crypto 200

    365.78
    +4.35 (+1.20%)
     
  • FTSE 100

    6,333.84
    -17.61 (-0.28%)
     
  • Nikkei 225

    25,527.37
    -106.93 (-0.42%)
     

Fate Therapeutics Inc (FATE) President and CEO J Scott Wolchko Sold $3.1 million of Shares

GuruFocus.com
·1 min read

- By insider

President and CEO of Fate Therapeutics Inc (30-Year Financial, Insider Trades) J Scott Wolchko (insider trades) sold 60,000 shares of FATE on 11/13/2020 at an average price of $51.87 a share. The total sale was $3.1 million.


Fate Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of programmed cellular immunotherapies for cancer and immune disorders. Fate Therapeutics Inc has a market cap of $4.61 billion; its shares were traded at around $52.80 with and P/S ratio of 233.64. GuruFocus has detected 3 severe warning signs with Fate Therapeutics Inc. .

CEO Recent Trades:

  • President and CEO J Scott Wolchko sold 60,000 shares of FATE stock on 11/13/2020 at the average price of $51.87. The price of the stock has increased by 1.79% since.

Directors and Officers Recent Trades:

  • General Counsel and Secretary Cindy Tahl sold 70,801 shares of FATE stock on 11/05/2020 at the average price of $50.47. The price of the stock has increased by 4.62% since.

For the complete insider trading history of FATE, click here

.This article first appeared on GuruFocus.